KCM
VKTX icon

Kennedy Capital Management’s Viking Therapeutics VKTX Stock Holding History

Kennedy Capital Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-42,391
Closed -$1.12M – 614
2025
Q2 		$1.12M Buy
42,391
+730
+2% +$19.2K 0.03% 497
2025
Q1 		$1.01M Sell
41,661
-1,358
-3% -$42.9K 0.02% 517
2024
Q4 		$1.73M Buy
43,019
+1,058
+3% +$60.3K 0.04% 538
2024
Q3 		$2.66M Sell
41,961
-5,025
-11% -$295K 0.06% 460
2024
Q2 		$2.49M Sell
46,986
-9,185
-16% -$602K 0.05% 480
2024
Q1 		$4.61M Sell
56,171
-45,517
-45% -$2.03M 0.09% 341
2023
Q4 		$1.89M Buy
+101,688
New +$1.33M 0.04% 504

Other funds holding VKTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return